Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Control Bionics Ltd
CBLCurrent price
0.062 AUD
+0.00000000003 AUD (+0.00%)
Last closed
0.062 AUD
Company
www.controlbionics.com
ISIN
AU0000114183
Sector
Healthcare
Industry
Medical Devices
Exchange
Australian Securities Exchange
Capitalization
15 137 581 AUD
Yield for 12 month
+16.98 %
1Y
3Y
5Y
10Y
15Y
CBL
Control Bionics Limited, together with its subsidiaries, engages in the research, development, commercialization, and sale of assistive communications technology systems in Australia, North America, and internationally. The company offers NeuroNode Trilogy, NeuroNode Duo, and Eye-gaze Duo systems that allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. It also provides Cosmos Connect, a small portable control device that can be used with a Windows display device; NeuroNode, a wireless wearable sensor that gives the user the ability to access their technology by bioelectric signals or spatial movements; Uno Touch, a speech generating device; and NeuroNode Duo, a wireless sensor. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is headquartered in Cremorne, Australia. Address: 11-13 Pearson Street, Cremorne, VIC, Australia, 3121
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
0.091 AUDP/E ratio
–Dividend Yield
–Current Year
+5 139 304 AUD
Last Year
+5 448 344 AUD
Current Quarter
+1 196 155 AUD
Last Quarter
+1 196 155 AUD
Current Year
+3 681 664 AUD
Last Year
+3 512 881 AUD
Current Quarter
+865 686 AUD
Last Quarter
+865 686 AUD
Key Figures CBL
1 year
3 years
5 years
10 years
EBITDA
-5 170 688 AUD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-41.41 %
PEG Ratio
–
Return On Equity TTM
-88.16 %
Wall Street Target Price
0.091 AUD
Revenue TTM
5 363 722 AUD
Book Value
0.031 AUD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-13 %
Dividend Yield
–
Gross Profit TTM
3 720 577 AUD
Earnings per share
-0.04 AUD
Diluted Eps TTM
-0.04 AUD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
-110.52 %
Dividend Analytics CBL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History CBL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation CBL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
3.1832
Price Sales TTM
2.8222
Enterprise Value EBITDA
-2.2282
Price Book MRQ
2.6068
Financials CBL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators CBL
For 52 weeks
0.033 AUD
0.11 AUD
50 Day MA
0.079 AUD
Shares Short Prior Month
–
200 Day MA
0.056 AUD
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart